AbstractStudies using an inhibitor of nitric oxide (NO) synthesis have suggested that endogenous NO may have a role in regulating endothelin release. We investigated the effect of endogenous and exogenous nitric oxide (NO) on the release of irET-1. l-NAME stimulated, but l-arginine inhibited irET-1 release. Perfusing sodium nitroprusside (SNP), however, did not inhibit irET-1 secretion. CyclicGMP, the second messenger for NO action, was stimulated by SNP but not by l-arginine. These data demonstrate that endogenous NO inhibits of irET-1, in a manner which is independent of cGMP, and suggest that this action may contribute to the vasodilatory effect of NO
We examined modulation by nitric oxide (NO) of sympathetic neurotransmitter release and vasoconstric...
1. Divergent evidence suggests that the intracellular signalling pathways for beta-adrenoceptor-medi...
Abstract—The level of renal blood flow (RBF) is controlled by opposing vasoconstrictor and vasodilat...
The enzyme nitric oxide (NO) synthase is present in the paraventricular nucleus, while nitric oxide ...
The enzyme nitric oxide (NO) synthase is present in the paraventricular nucleus, while nitric oxide ...
sen. Exogenous NO inhibits basal NO release from vascular endothelium in vitro and in vivo. Am. J. P...
The present study was designed to investigate the role of nitric oxide (NO) in the regulation of adr...
Endothelium-mediated regulation of renin secretion. The aim of the present study was to investigate ...
To evaluate whether sympathetic activity induces nitric oxide (NO) production, we perfused the rat a...
Injection of N omega-nitro-L-arginine methyl ester (L-NAME), an L-arginine analogue and a potent inh...
Activation of renin synthesis is dependent on intact nitric oxide production. The present study inve...
Acute inhibition of nitric oxide (NO) synthase (NOS) augments the release of endothelium-derived con...
The overall aim of this study was to determine if endogenous nitric oxide (NO) and/or cyclooxygenase...
Vascular endothelin (ET) type B (ETB) receptors exert dilator and constrictor actions in a complex i...
1. L-Arginine prevents adrenocorticotrophin (ACTH)-induced hypertension in the rat. To confirm that ...
We examined modulation by nitric oxide (NO) of sympathetic neurotransmitter release and vasoconstric...
1. Divergent evidence suggests that the intracellular signalling pathways for beta-adrenoceptor-medi...
Abstract—The level of renal blood flow (RBF) is controlled by opposing vasoconstrictor and vasodilat...
The enzyme nitric oxide (NO) synthase is present in the paraventricular nucleus, while nitric oxide ...
The enzyme nitric oxide (NO) synthase is present in the paraventricular nucleus, while nitric oxide ...
sen. Exogenous NO inhibits basal NO release from vascular endothelium in vitro and in vivo. Am. J. P...
The present study was designed to investigate the role of nitric oxide (NO) in the regulation of adr...
Endothelium-mediated regulation of renin secretion. The aim of the present study was to investigate ...
To evaluate whether sympathetic activity induces nitric oxide (NO) production, we perfused the rat a...
Injection of N omega-nitro-L-arginine methyl ester (L-NAME), an L-arginine analogue and a potent inh...
Activation of renin synthesis is dependent on intact nitric oxide production. The present study inve...
Acute inhibition of nitric oxide (NO) synthase (NOS) augments the release of endothelium-derived con...
The overall aim of this study was to determine if endogenous nitric oxide (NO) and/or cyclooxygenase...
Vascular endothelin (ET) type B (ETB) receptors exert dilator and constrictor actions in a complex i...
1. L-Arginine prevents adrenocorticotrophin (ACTH)-induced hypertension in the rat. To confirm that ...
We examined modulation by nitric oxide (NO) of sympathetic neurotransmitter release and vasoconstric...
1. Divergent evidence suggests that the intracellular signalling pathways for beta-adrenoceptor-medi...
Abstract—The level of renal blood flow (RBF) is controlled by opposing vasoconstrictor and vasodilat...